Vanguard Personalized Indexing Management, LLC Amicus Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,955 shares of FOLD stock, worth $70,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,955
Previous 19,349
43.38%
Holding current value
$70,331
Previous $182,000
51.1%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FOLD
# of Institutions
314Shares Held
322MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$187 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$187 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$156 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$138 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$132 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.8B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...